These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 972004)

  • 1. Effect of tetracycline on calcium oxalate calculi: in vivo and in vitro studies.
    Selikowitz SM; Olsson CA
    Invest Urol; 1976 Sep; 14(2):124-7. PubMed ID: 972004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of anticalculus management in the rat.
    Selikowitz SM; Olsson CA
    Invest Urol; 1976 Sep; 14(2):120-3. PubMed ID: 972003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of takusha and kagosou on calcium oxalate renal stones in rats].
    Yamaguchi S; Jihong L; Utsunomiya M; Yoshioka T; Okuyama A; Koide T; Sugiyama K
    Hinyokika Kiyo; 1995 Jun; 41(6):427-31. PubMed ID: 7645450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of magnesium and pH on experimental calcium oxalate stone disease.
    Borden TA; Lyon ES
    Invest Urol; 1969 Jan; 6(4):412-22. PubMed ID: 5773525
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
    Stitchantrakul W; Sopassathit W; Prapaipanich S; Domrongkitchaiporn S
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1028-33. PubMed ID: 15916110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An experimental study of effect of different extracts of Alisma orientalis on urinary calcium oxalate stones formation in rats].
    Cao ZG; Liu JH; Radman AM; Wu JZ; Ying CP; Zhou SW
    Zhongguo Zhong Yao Za Zhi; 2003 Nov; 28(11):1072-5. PubMed ID: 15615421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of early time calcium oxalate nephrolithiasis.
    Jordan WR; Finlayson B; Luxenberg M
    Invest Urol; 1978 May; 15(6):465-8. PubMed ID: 649295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
    Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Animal-experiment studies on the effect of magnesium and vitamin B 6 on calcium-oxalate nephrolithiasis].
    Schneider HJ; Hesse A; Berg W; Kirsten J; Nickel H
    Z Urol Nephrol; 1977 Jun; 70(6):419-27. PubMed ID: 906678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of calcium oxalate calculi using Reducto-Special].
    Swoboda G
    Wien Med Wochenschr; 1977 Jun; 127(13):431-2. PubMed ID: 899035
    [No Abstract]   [Full Text] [Related]  

  • 14. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxalate and renal stone formation.
    Tiselius HG
    Scand J Urol Nephrol Suppl; 1980; 53():135-48. PubMed ID: 6937989
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of allopurinol action in calcium oxalate stone formers.
    Tomlinson B; Al-Khader A; Cohen SL; Kasidas GP; Krywawych S; Edgar L; Rose GA
    Proc Eur Dial Transplant Assoc; 1981; 18():556-60. PubMed ID: 6276882
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.